ANN ARBOR, Mich.-based Adeona Pharmaceuticals, a developer of medicines for serious central nervous system diseases, announced that Ashley I. Bush, M.D., Ph.D., has joined the company's scientific advisory board.

Bush is a National Health and Medical Research Council-Australia fellow and head of the Oxidation Disorders Laboratory for the Mental Health Research Institute, University of Melbourne. He has also served as the director of the Laboratory for Oxidation Biology, Massachusetts General Hospital and associate professor of psychiatry at Harvard Medical School. He is a board certified psychiatrist and a co-founding scientist of Prana Biotechnology.